BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26559852)

  • 1. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation.
    Sarma A; Giugliano RP
    Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the perioperative patient on direct oral anticoagulants.
    Leitch J; van Vlymen J
    Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring and reversal strategies for new oral anticoagulants.
    Vanden Daelen S; Peetermans M; Vanassche T; Verhamme P; Vandermeulen E
    Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):95-103. PubMed ID: 25431993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding.
    Palareti G
    Semin Hematol; 2014 Apr; 51(2):102-11. PubMed ID: 24861794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants: unique properties and practical approaches to management.
    Barnes GD; Kurtz B
    Heart; 2016 Oct; 102(20):1620-6. PubMed ID: 27402803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the perioperative management of direct oral anticoagulants: concerns and considerations.
    Ibrahim A; Walsh LG; Algaali M; Satti Z; Kiernan TJ; Yan BP
    Expert Opin Pharmacother; 2019 Mar; 20(4):465-472. PubMed ID: 30521411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants: new drugs and new concepts.
    Levy JH; Spyropoulos AC; Samama CM; Douketis J
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of direct oral anticoagulant therapy reversal.
    Gulseth MP
    Am J Health Syst Pharm; 2016 May; 73(10 Suppl 2):S5-S13. PubMed ID: 27147458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants (DOAC) - Management of emergency situations.
    Lindhoff-Last E
    Hamostaseologie; 2017; 37(4):257-266. PubMed ID: 29582928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Oral Anticoagulants in Chronic Liver Disease.
    Steuber TD; Howard ML; Nisly SA
    Ann Pharmacother; 2019 Oct; 53(10):1042-1049. PubMed ID: 30947523
    [No Abstract]   [Full Text] [Related]  

  • 13. Current knowledge on assessing the effects of and managing bleeding and urgent procedures with direct oral anticoagulants.
    Dager W; Hellwig T
    Am J Health Syst Pharm; 2016 May; 73(10 Suppl 2):S14-26. PubMed ID: 27147455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis.
    Rong F; Jia B; Huang P; Lynn HS; Zhang W
    Thromb Res; 2015 Jun; 135(6):1117-23. PubMed ID: 25891842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What gastroenterologists should know about direct oral anticoagulants.
    Radaelli F; Fuccio L; Paggi S; Bono CD; Dumonceau JM; Dentali F
    Dig Liver Dis; 2020 Oct; 52(10):1115-1125. PubMed ID: 32532603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.
    Crawley RM; Anderson RL
    Drugs; 2020 Sep; 80(13):1293-1308. PubMed ID: 32691292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban: an oral factor Xa inhibitor.
    Thomas TF; Ganetsky V; Spinler SA
    Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROTEM Testing for Direct Oral Anticoagulants.
    Korpallová B; Samoš M; Bolek T; Kühnelová L; Škorňová I; Kubisz P; Staško J; Mokáň M
    Semin Thromb Hemost; 2021 Oct; 47(7):815-823. PubMed ID: 34130343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.